Mitsubishi UFJ Financial Group
8306
Toyota Motor
7203
Mitsubishi
8058
4
Nintendo
7974
5
Nippon Telegraph & Telephone
9432
JP Stock MarketDetailed Quotes
4588 Oncolys BioPharma
- 532
- -17-3.10%
20min DelayMarket Closed Apr 4 15:30 JST
13.28BMarket Cap-4.88P/E (Static)
551High505Low1.43MVolume543Open549Pre Close748.40MTurnover91852wk High6.27%Turnover Ratio24.96MShares42052wk Low-95.72EPS TTM12.10BFloat Cap4410Historical HighLossP/E (Static)22.75MShs Float401Historical Low-108.92EPS LYR8.38%Amplitude--Dividend TTM4.81P/B100Lot Size--Div YieldTTM
About Oncolys BioPharma Company
Oncolys BioPharma Inc develops pharmaceutical products. The company is engaged in research and development of oncolytic viruses, drugs for serious infectious diseases, molecular targeted anti-cancer drugs, and tumor diagnostic agents.
Company Profile
Symbol4588
Company NameOncolys BioPharma
Founded2004-03-18
MarketTSE Growth
Fiscal Year Ends12-31
Address4-1-28 Toranomon Toranomon Towers Office
Zip Code105-0001
Phone03-5472-1578
Websitewww.oncolys.com
Company Executives
- Name
- Position
- Salary
- Yasuo Urata
- President and Chief Executive Officer, Research and Development and CMC
- --
- Yasunari Katagihara
- Director of Business Development and Risk Management
- --
- Yasushi Saitou
- Independent Director
- --
- Naoko Iino
- Independent Director
- --